Igarashi R, Yamashita S, Yamashita T, Inoue K, Fukuda T, Fukuchi T, et al. Gemcitabine induces Parkin-independent mitophagy through mitochondrial-resident E3 ligase MUL1-mediated stabilization of PINK1. Sci Rep. 2020;10:1465 pubmed publisher

Hua Y, Shun T, Strock C, Johnston P. High-content positional biosensor screening assay for compounds to prevent or disrupt androgen receptor and transcriptional intermediary factor 2 protein-protein interactions. Assay Drug Dev Technol. 2014;12:395-418 pubmed publisher

Moshiri H, Mehta V, Yip C, Salavati R. Pilot-scale compound screening against RNA editing identifies trypanocidal agents. J Biomol Screen. 2015;20:92-100 pubmed publisher

Bruner J, Zou B, Zhang H, Zhang Y, Schmidt K, Li M. Identification of novel small molecule modulators of K2P18.1 two-pore potassium channel. Eur J Pharmacol. 2014;740:603-10 pubmed publisher

Sturchler E, Chen W, Spicer T, Hodder P, McDonald P, Duckett D. Development of an HTS-compatible assay for the discovery of ASK1 signalosome inhibitors using alphascreen technology. Assay Drug Dev Technol. 2014;12:229-37 pubmed publisher

Freitas J, Miller N, Mengeling B, Xia M, Huang R, Houck K, et al. Identification of thyroid hormone receptor active compounds using a quantitative high-throughput screening platform. Curr Chem Genom Transl Med. 2014;8:36-46 pubmed publisher

Wyhs N, Walker D, Giovinazzo H, Yegnasubramanian S, Nelson W. Time-Resolved Fluorescence Resonance Energy Transfer Assay for Discovery of Small-Molecule Inhibitors of Methyl-CpG Binding Domain Protein 2. J Biomol Screen. 2014;19:1060-9 pubmed publisher

Dahlin J, Sinville R, Solberg J, Zhou H, Han J, Francis S, et al. A cell-free fluorometric high-throughput screen for inhibitors of Rtt109-catalyzed histone acetylation. PLoS ONE. 2013;8:e78877 pubmed publisher

Robinson J, Smith A, Sturchler E, Tabrizifard S, Kamenecka T, McDonald P. Development of a high-throughput screening-compatible cell-based functional assay to identify small molecule probes of the galanin 3 receptor (GalR3). Assay Drug Dev Technol. 2013;11:468-77 pubmed publisher

Horiuchi K, Eason M, Ferry J, Planck J, Walsh C, Smith R, et al. Assay development for histone methyltransferases. Assay Drug Dev Technol. 2013;11:227-36 pubmed publisher

Quintavalle M, Elia L, Price J, Heynen Genel S, Courtneidge S. A cell-based high-content screening assay reveals activators and inhibitors of cancer cell invasion. Sci Signal. 2011;4:ra49 pubmed publisher

Evers B, Schut E, van der Burg E, Braumuller T, Egan D, Holstege H, et al. A high-throughput pharmaceutical screen identifies compounds with specific toxicity against BRCA2-deficient tumors. Clin Cancer Res. 2010;16:99-108 pubmed publisher

Miller C, Nisa S, Dempsey S, Jack C, O Toole R. Modifying culture conditions in chemical library screening identifies alternative inhibitors of mycobacteria. Antimicrob Agents Chemother. 2009;53:5279-83 pubmed publisher

Johnston C, Willard F, Ramer J, Blaesius R, Roques C, Siderovski D. State-selective binding peptides for heterotrimeric G-protein subunits: novel tools for investigating G-protein signaling dynamics. Comb Chem High Throughput Screen. 2008;11:370-81 pubmed

Diamandis P, Wildenhain J, Clarke I, Sacher A, Graham J, Bellows D, et al. Chemical genetics reveals a complex functional ground state of neural stem cells. Nat Chem Biol. 2007;3:268-73 pubmed

Lazo J, Brady L, Dingledine R. Building a pharmacological lexicon: small molecule discovery in academia. Mol Pharmacol. 2007;72:1-7 pubmed

Rickardson L, Wickström M, Larsson R, Lövborg H. Image-based screening for the identification of novel proteasome inhibitors. J Biomol Screen. 2007;12:203-10 pubmed

Valley M, Zhou W, Hawkins E, Shultz J, Cali J, Worzella T, et al. A bioluminescent assay for monoamine oxidase activity. Anal Biochem. 2006;359:238-46 pubmed

Rickardson L, Fryknäs M, Haglund C, Lövborg H, Nygren P, Gustafsson M, et al. Screening of an annotated compound library for drug activity in a resistant myeloma cell line. Cancer Chemother Pharmacol. 2006;58:749-58 pubmed

Benjamin E, Pruthi F, Olanrewaju S, Ilyin V, Crumley G, Kutlina E, et al. State-dependent compound inhibition of Nav1.2 sodium channels using the FLIPR Vm dye: on-target and off-target effects of diverse pharmacological agents. J Biomol Screen. 2006;11:29-39 pubmed